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I
n the Alzheimer brain, the two hallmark pathological lesions,
ﬁrst described by Dr. Alzheimer in 1906, are senile plaques
1
and neuroﬁbrillary tangles (NFTs).
2 In Alzheimer’s disease
(AD), senile plaques and NFTs simultaneouslyaggregate. These
two aggregation processes appear to occur independently be-
cause the senile plaques are extracellular deposits which develop
around nerve endings and consist primarily of Aβ oligomers,
while the NFTs are intracellular lesions which develop in
neuronal cell bodies and comprise primarily of aggregates of
the microtubule (MT)-binding protein tau. Yet, recently it has
been shown in vivo that Aβ binds to tau to form soluble stable
complexes, and this binding can promote aggregation.
3 Impor-
tantly,thepresenceofbothAβandtaucausearapiddissociation
oftaufromthemicrotubulesandacollapseofaxonalstructure—
leading ﬁrst to the malfunction of the synapses and ultimately to
the neurons’ death.
4
Further studies have shown synergy between the tau and Aβ
pathology in the mitochondria,
5 9 and it was suggested that Aβ
may accelerate tau NFT formation.
10 12 Recentexperiments led
tofourdiﬀerent mechanismsthrough whichAβcanpromotethe
tau pathology:
13,14 (1) in vitro neuronal exposure to Aβ induces
activation of GSK3β which increases tau phosphorylation,
15 17
thus triggering cell death by destabilizing the microtubule
network; (2) the inﬂammatory response may provide a link
between Aβ and tau pathology in AD;
18 (3) the increased levels
of Aβ may lead to proteasomal impairment within the brain and
the degradation of tau;
19,20 and ﬁnally (4) transport deﬁcits may
lead to tau pathology as readily as tau pathology may lead to
transport deﬁcit.
21,22
These studies emphasize that to understand the mechanism
through which Aβ tau complexes lead to AD pathology the
interactions between Aβ and tau should be probed. Tau is a
natively disordered protein which binds and stabilizes micro-
tubules and shares structural features with amyloid ﬁbrils.
Amyloid oligomers, amyloid ﬁbrils, and ﬁbrils of tau protein
23
have a predominantly cross-β pleated sheet conformation in
which the polypeptide backbone is perpendicular to the ﬁbril
axis.Thelongesthumantauisoformhtau40wasobservedtoexist
in the central nervous system. It consists of 441 residues and
contains several domains, including the proline rich ﬂanking
regions P1 and P2 (residues 151 244) and four repeats R1 R4
(residues 244 369) (Figure 1). All four repeats constitute the
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ABSTRACT: Amyloid plaques and neuroﬁbrillary tangles
simultaneously accumulate in Alzheimer’s disease (AD). It is
known that Aβ and tau exist together in the mitochondria;
however, the interactions between Aβ oligomers and tau are
controversial. Moreover, it is still unclear which speciﬁc do-
mains in the tau protein can interact with Aβ oligomers and
what could be the eﬀect of these interactions. Herein, we
examine three diﬀerent Aβ tau oligomeric complexes. These
complexes present interactions of Aβ with three domains in the
tau protein; all contain high β-structure propensity in their R2, R3, and R4 repeats. Our results show that, among these, Aβ
oligomers are likely to interact with the R2 domain to form a stable complex with better alignment in the turn region and the
β-structure domain. We therefore propose that the R2 domain can interact with soluble Aβ oligomers and consequently promote
aggregation.EMandAFMimagesanddimensionsrevealedhighlypolymorphictauaggregates.Wesuggestthatthepolymorphictau
and Aβ tau aggregates may be largely due to repeat sequences which are prone to variable turn locations along the tau repeats.5173 dx.doi.org/10.1021/bi200400u |Biochemistry 2011, 50, 5172–5181
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microtubule-binding domain, and residues in repeats R2 R4
possess a high propensity to adopt a β-structure.
24 27 Figure 1
illustrates the secondary structure of the three repeats indicating
the propensity of β-structure. AFM, FT-IR, CD, and X-ray
ﬁber diﬀraction experiments have shown that fragments of the
β-structure in these repeats can stably interact with each
other and with themselves and can aggregate into ﬁbrils.
28 30
Petterson and co-workers
31 suggested that the hexapeptides
motifs
275VQIINK
280 and
306VQIVYK
311 in repeats R2 and
R3, respectively, act as mediators of intermolecular interactions
between tau monomers which were stabilized by the anionic
factorheparin.EPRspectraandEMmeasurementsalsoindicated
that fragments in the R2 repeat of tau have a parallel in-register
arrangement of β-strands.
32 Monte Carlo simulations
33 of the
306VQIVYK
311 in repeat R3 have shown that the tau molecule
not only promotes the formation of stable oligomers but also is
capableofstabilizingthesestructuresbecause suchfragmentsare
characteristically rich in β-sheet structures. The simulations
33
have shown that the
306VQIVYK
311 fragment in repeat R3 has a
mostly parallel arrangement of β-strands.
According to the experimental studies above, tau aggregation
occurs via interactions between β-strand fragments in the tau
protein. Furthermore, they indicate that tau interacts with Aβ.
Since all amyloidogenic peptides, including the tau protein,
polymerize into ﬁbrils, have very similar properties and share
similar sheet intermediates, it is conceivable that they may
interact with these β-pleated sheet domains via a similar ﬁbril
formation mechanism; however, how and which interactions
between amyloidogenic peptides and tau protein could be
involved in ﬁbril formation are not completely understood. Here
wetestinteractionsbetweentauandAβbyconstructingAβ tau
oligomer complexes: we combine fragments of tau R2, R3, and
R4 repeats with Aβ1 42 and Aβ17 42 oligomers to ﬁgure out the
preferred tau repeat Aβ interactions and organization. Our
study revealed a stable Aβ tau oligomer complex where the
fragment in tau protein that interacts with Aβ to form a stable
association derives from repeat R2, while those fragments from
repeats R3 and R4 which interact with Aβ exhibit less stable
oligomeric conformations. Nonetheless, amyloids are inherently
polymorphic,
34,35 and Aβ tau complexes are also expected to
present a rugged landscape, e.g., through variants of turn shapes
and sizes and shifts in residue registration in β-strands via side-
chainorientations.Understandingtherangeofstructuralfeatures
of the aggregates is important for eﬀective drug design to reduce
aggregate formation.
’MATERIALS AND METHODS
Molecular Dynamics (MD) Simulations Protocol. MD si-
mulationsofsolvatedtauandtau Aβoligomerswereperformed
in the NPT ensemble using the NAMD program
36 with the
CHARMM27 force field.
37,38 The oligomers were energy mini-
mized and explicitly solvated in a TIP3P water box
39,40 with a
minimum distance of 15 Å from any edge of the box to any Aβ
atom. Any water molecule within 2.5 Å of the Aβ was removed.
Counterions Na
þ were added at random locations to neutralize
the Aβ charge. The Langevin piston method
36,41,42 with a decay
periodof100fsandadampingtimeof50fswasusedtomaintain
a constant pressure of 1 atm. The temperature 330 K was
controlled by Langevin thermostat with a damping coefficient
of10ps
 1.
36Theshort-rangevanderWaals(VDW)interactions
were calculated using the switching function, with a twin range
cutoff of 10.0 and 12.0 Å. Long-range electrostatic interactions
were calculated using the particle mesh Ewald method with a
cutoff of 12.0 Å.
43,44 The equations of motion were integrated
using the leapfrog integrator with a step of 1 fs.
The solvated systems were energy minimized for 2000 con-
jugated gradient steps, where the hydrogen bonding distance
between the β-sheets in Aβ17 42 is ﬁxed in the range 2.2 2.5 Å.
Thecounterionsandwatermoleculeswereallowedtomove.The
hydrogen atoms were constrained to the equilibrium bond using
the SHAKE algorithm.
45 The minimized solvated systems were
energy minimized for additional 5000 conjugate gradient steps
and 20000 heating steps at 250 K, with all atoms allowed to
move. Then, the systems were heated from 250 to 300 K for
300 ps and equilibrated at 330 K for 300 ps. All simulations ran
for 30 ns. These conditions are applied to all cases.
Figure1. Domainorganizationsofthetauisoformhtau40consistsof441residuesandcontainsseveralimportantdomains:fourpseudorepeatsR1 R4
and two proline-rich ﬂanking regions P1 and P2. The colors in the primary sequence of the pseudorepeats R2, R3, and R4 highlight the secondary
structure of the repeats: β-structure (red), turn structure (blue), and disordered structure (green).5174 dx.doi.org/10.1021/bi200400u |Biochemistry 2011, 50, 5172–5181
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G e n e r a l i z e dB o r nM e t h o dw i t hM o l e c u l a rV o l u m e( G B M V ) .
To obtain the relative structural stability of tau, Aβ,a n dt a u  Aβ
oligomers, the oligomer trajectories of the last 5 ns were first
extracted from the explicit MD simulation excluding water mole-
cules.Thesolvationenergiesofallsystemswerecalculatedusingthe
generalized Born method with molecular volume (GBMV).
46,47
In the GBMV calculations, the dielectric constant of water was
set to 80. The hydrophobic solvent-accessible surface area
(SASA) term factor was set to 0.00592 kcal/(mol Å
2). Each
conformer is minimized using 1000 cycles, and the conforma-
tional energy is evaluated by grid-based GBMV. The minimiza-
tion does not change the conformations of each conformer; it
only relaxes the local geometries due to thermal fluctuation
which occurred during the MD simulations.
Analysis Details. We examined the structural stability of the
studied oligomers by following the changes in the number of the
hydrogen bonds between β-strands with the hydrogen bond
cutoffsetto2.5Åandbymonitoringthechangeintheintersheet
distance(CRbackbone backbone distance)inthecoredomain
of all of the oligomers. In all models we constructed, the core
domain is between residue 22 and residue 35, as previously done
by Miller et al.
34
We further investigated the averaged water molecules around
eachside-chainCβcarbonwithin4Å,forthetauoligomersfrom
repeat R2 with and without interactions with Aβ17 42 and,
similarly, Aβ1 42.
’RESULTS
Construction of the Conformational Ensemble of Aβ with
Tau Repeats. Interactions between the Aβ amyloid and the
tau protein are more likely to appear in regions of residual
β-structure in the tau protein that have the potential to serve as
seeds for aggregation. Mutations in tau repeats were shown
to lead to a strong tendency for aggregation which correlates
with their high propensity of β-structure.
48 Our constructed
Aβ oligomers, tau oligomers, and Aβ tau oligomeric complexes
are based on the NMR model of L€ uhrs et al.
49 for the Aβ17 42
structure and on recent experimental data
25,50 that provide some
details of the secondary structure of the tau protein, such as
β-structure and the position of the U-turn in the sequence. We
also constructed Aβ tau oligomeric complexes using the NMR
model of Tycko and co-workers;
51 however, our simulations
revealed unstable complexes (Figure S1). To match tau with
Aβ17 42 oligomers, we extracted tau fragments that have the
abilitytoserveasseedsforaggregation.Thehighestpropensityof
β-structurecontentinthetauproteinisinrepeatsR2,R3,andR4
(Figure 1). These repeats are known to be involved in the
abnormal aggregation of tau.
25,50 Moreover, the high propensity
of β-structures in these repeats is also known to be essential
for paired helical filaments formation.
28,48 In addition to the
β-structure in the repeats, we also consider other similar struc-
tural properties between Aβ and each of the R2, R3, and R4
repeats. More specifically, we consider the tendency to form
stable interactions between Aβ and tau repeats in both the
β-structure domain and the U-turn domain, e.g., hydrophobic
interactions,electrostaticinteractions,polarinteractions,andsalt
bridge that stabilize the turn. Consequently, the tau repeats
consist of two β-strands connected by U-turn, similarly to Aβ
peptides.
Recent EM and AFM images and dimensions of the tau
ﬁbrils
52 revealed that only the R2, R3, and R4 tau repeats can
ﬁt. It is likely that the other tau protein domains that do nothave
a preponderance for β-structure “hang out” and are not part of
the regular ﬁbrillar organization. In constructing the ﬁbril, we
assume that the conventional turn shape in Aβ oligomers, which
is also observed in other amyloids,
53,54 can act as seed for
fragments of tau repeat oligomers and examine whether the
simulated tau and Aβ tau oligomers can retain the β-strand-
turn-β-strand shape. Our assumption is based on the fact that
amyloidsfromdiﬀerentspeciesorwithdiﬀerentsequences(such
as in prion) have close structural similarity.
55 We further assume
that the secondary structures of octamers of the tau repeats R2,
R3, and R4 studied here are similar to those of Aβ oligomers, as
illustrated by experimental studies
25,50 and detailed below.
To construct Aβ tau oligomeric complexes, we used tetra-
mersofrepeatsR2,R3,andR4andassociatedeachtetramerwith
Aβ17 42tetramers.Weﬁrsttestensembleofalignmentsbetween
Aβ17 42 and sequences in tau repeats which maximize the
overlap between the hydrophobic residues. For example, hydro-
phobic residues in the
275VQIINK
280 motif in repeat R2 can
match the hydrophobic residues
17LVFFAE
22 in Aβ (Figure 2),
and the U-turn and C-terminal regions of Aβ can then super-
impose on the continuous repeat sequence in tau. Similarly, the
ﬁtting of the hydrophobic residues in
306VQIVY
310 motif in
repeat R3 matches the Aβ
17LVFFA
21 segment (Figure 3) and
the R4 repeat
337VEVK
310 motif matches the Aβ
17LVFF
20
segment (Figure 4). The ﬁnal alignments are indicated in
Figures 2, 3, and 4 for the R2, R3, and R4 repeats, respectively.
As can be seen for repeat R2, four hydrophobic interactions
betweentauandAβappearinoneβ-strandandtwohydrophobic
interactions appear in the second. For repeat R3, ﬁve hydro-
phobicinteractionsbetweentauandAβappearintheﬁrststrand
and two hydrophobic interactions in the second. Finally, for
repeat R4, three hydrophobic interactions between tau and Aβ
Figure 2. Initial structural models: (A)Aβ17 42 tetramer interacts with
tau tetramer and (B) tau octamer. The tau protein fragment of each
monomer is taken from the repeat R2. Blue arrows illustrate hydro-
phobic interactions between Aβ17 42 and repeat R2.5175 dx.doi.org/10.1021/bi200400u |Biochemistry 2011, 50, 5172–5181
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appearinonestrandandtwohydrophobicinteractionsappearin
the second.
Considering the β-structures and the turn regions in repeats
R2,R3,andR4intau,
50weconstructedthreeparalleloctamersof
26 continuous residues from each repeat which form organiza-
tions similar to those obtained previously by Miller et al.
34 for
Aβ17 42octamers: the ﬁrst octamer consistsof a fragment in repeat
R2, residues V275 V300 (Figure 2), the second of a fragment in
R3, residues V306 K331 (Figure 3), and the third octamer
consists of a fragment in R4, residues V337 H362 (Figure 4).
We further constructed the full-length Aβ1 42 dodecamer by
applying the L€ uhrs model
49 (PDB code ID: 2BEG) for Aβ17 42.
Then, for each monomer we linked residues 1 16 in a manner
similar to our recent construction of the tubular Aβ1 42 ﬁbrils.
56
Forthetaudodecamer,onlytheR2repeatwasused;however,we
extendedthesequenceintheN-terminalforthestructure shown
in Figure 2A, i.e., each monomer in the tau oligomer consists of
residues K259 V300. Finally, we constructed the Aβ1 42 tau
dodecamer complex by interacting hexamers of Aβ1 42 with
hexamers of the tau fragment K259 V300. Figure 5 illustrates
the tau, Aβ1 42 and Aβ1 42 tau oligomers.
Reaction Coordinates for the Formation of Aβ Tau Oli-
gomeric Complexes from Aβ and Tau Oligomers Demon-
strate That the R2 Repeat in Tau Is More Likely to Interact
with Aβ. To investigate the stability of each soluble Aβ tau
oligomeric complex for each of the fragments in repeats R2, R3,
and R4 interacting with Aβ, the conformational energies were
computed for Aβ oligomers, tau oligomers, and the Aβ tau
oligomeric complexes (Table 1). The conformational energies for
each oligomer are based on the energy computed with the general-
ized Born method with molecular volume (GBMV).
46,47 We
estimate the relative stability of each Aβ tau oligomeric complex
by comparingitsenergy withthetwo separatecomponents,Aβand
tau oligomers, as illustrated by the following chemical “reaction”:
ðΑβÞ2n þð TauÞ2n S 2½ðΑβÞn 3ðTauÞn ð 1Þ
where n indicates the number of monomers within an oligomer.
Figure6demonstratesthereactioncoordinatesforthethreerepeats.
AsseenfromFigure6,theAβ tauR2repeatoligomericcomplexis
more stableenergetically thanitstwo separate components, Aβand
tau oligomers. One can view the reaction coordinates for R2 as an
exothermic reaction, where the product (Aβ tau oligomeric com-
plex) is more stable than the reactants (Aβ and tau oligomers).
However, for the repeats R3 and R4, the picture is the opposite: the
two separate Aβ and tau oligomer components are more stable
than the Aβ tau oligomeric complex. Hence, these relative
stabilities calculations indicate that repeat R2 in the tau protein
is more likely to have the ability to interact with Aβ to form a
stable oligomeric complex.
Tau Repeat R2 Oligomers Structurally Stabilize the Aβ
Oligomers.WhileparallelAβoligomersarestableinexperiment
Figure 3. Initial structural models: (A)Aβ17 42 tetramer interacts with
tau tetramer and (B) tau octamer. The tau protein fragment of each
monomer is taken from repeat R3. Blue arrows illustrate hydrophobic
interactions between Aβ17 42 and repeat R3.
Figure 4. Initial structural models: (A)Aβ17 42 tetramer interacts with
tautetramerand(B)tauoctamer.Thetaufragmentofeachmonomeris
taken from repeat R4. Blue arrows illustrate hydrophobic interactions
between Aβ17 42 and repeat R4.
Table1. ConformationalEnergyoftheConstructedOligomers
oligomer model
conformational energy
a
(kcal/mol) Figure
Aβ17 42  2244.66 (103.01) Fig. 6 and Fig. 1B in Ref. 34
Aβ17 42 tau R2  4238.12 (99.15) Fig. 2A
Aβ17 42 tau R3  2757.63 (104.40) Fig. 3A
Aβ17 42 tau R4  5319.35 (116.07) Fig. 4A
Tau R2  6206.32 (127.23) Fig. 2B
Tau R3  3387.86 (106.66) Fig. 3B
Tau R4  8580.03 (128.77) Fig. 4B
aConformational energies were computed using the GBMV calcula-
tions. The standard deviation values are presented in parentheses.5176 dx.doi.org/10.1021/bi200400u |Biochemistry 2011, 50, 5172–5181
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and simulations, experimental structural data of soluble Aβ tau
oligomericcomplexesareunavailable.Herein, wetestmodelsfor
parallel Aβ tau oligomeric complexes and parallel tau oligo-
mers. We investigate their conformational stability by analysis of
the hydrophobic association among the β strands.
Previously, Miller et al.
34 demonstrated that for the Aβ17 42
parallel octamers based on the L€ uhrs model >70% of the
hydrogen bonds are retained during the 30 ns simulations, and
theβ-sheetdistancesacrosstheU-turnareinthe12 13Årange.
Here, for the Aβ17 42 tau R2 oligomeric complex, >70% of the
hydrogen bonds are also retained during the simulations, and
assisted by the backbone hydrogen bonds, the association is
slightly better among the β-strands compared with the Aβ17 42
parallel octamer (Figure 7A). We also examined three diﬀerent
β-sheet distances across the U-turn for the Aβ17 42 tau oligo-
meric complexes: between two β-sheets of Aβ, between two
β-sheets of the tau repeat, and between a monomer of Aβ and a
nearby monomer of a tau repeat (Figure 8). All three β-sheet
distances across the U-turn for Aβ17 42 tau R2 oligomeric
complex are in the ∼12 13 Å range, indicating that the tau
R2 oligomers stabilize the Aβ17 42 oligomers. In contrast, both
Aβ17 42 tau R3 and Aβ17 42 tau R4 oligomeric complexes
demonstrate diﬀerent values, in the range of 12 15 and 10 
20Å,respectively.Prolineresiduesaredisfavoredinβ-structures.
In repeat R3, Pro312 may explain the relatively large β-sheet
distances across the U-turn for Aβ17 42 tau R3 oligomers.
Figure5. Initialstructuralmodels:(A)Aβ1 42tetramerinteractswithtautetramerand(B)tauoctamer.Thetauproteinfragmentofeachmonomeris
taken from repeat R2.
Figure 6. Relative energies of the two separate components Aβ and tau and of Aβ tau complex for repeats R2, R3, and R4.5177 dx.doi.org/10.1021/bi200400u |Biochemistry 2011, 50, 5172–5181
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The large β-sheet distances across the U-turn for Aβ17 42 tau
R4 are due to the few hydrophobic interactions between the two
β-strands (three hydrophobic interactions between the Aβ
peptide and tau repeat in one strand and only two appear in
the second). Although there are similarities in the structural
properties in the turn region for Aβ17 42 tau for both repeats
R3 and R4, the interactions between the β-strands are probably
more important for structural stability than the turn region.
Although the Aβ17 42 tau R3 and Aβ17 42 tau R4 oligomeric
complexes present only slightly less than 70% of their hydrogen
bonds for the last 10 ns of the simulations (Figure 7A), the
diﬀerences among the β-sheet distances suggest that the repeats
R3 and R4 are less preferred to interact with Aβ (Figure 9B,C).
Interestingly,intauoligomersconsistingofrepeatsR3andR4,
the percentage of hydrogen bonds that are retained during the
simulations are less than 60% for R3 and less than 50% for R4,
while in repeat R2, >70% of the hydrogen bonds are retained.
Hence, the tau oligomer with the R2 repeat has a better
association among the β-strands assisted by backbone hydrogen
bonds (Figure 7B), indicating thatrepeatR2hasahighpropensity
of β-structures that may interact with Aβ to form a stable oligomer.
We note that the percentages of hydrogen bonds in Aβ tau
oligomeric complexes for all repeats and in particular for R3 and
R4 are higher than in tau oligomers that seem to have similar
structural properties. The reason for this diﬀerence could lie in the
electrostatic interactions between the β-strands: for Aβ tau R2, two
(Aβ Glu22 tau Lys280; Aβ Asp23 tau K281); for Aβ tau R3,
one (Aβ Glu22 tau K311); and for Aβ tau R4, one interaction
(Aβ Asp23 tau K343). Yet, the β-sheet distances expand to
20 21 Åfor tau R2 oligomers; therefore, the R2 repeat interacts
more favorably with Aβ than with itself.
Solvation of Backbone Residues in Tau and Aβ tau
Oligomeric Complexes Indicate the Stability of the Com-
plexes. We further examine the stability of the Aβ tau R2
oligomeric complexes by investigating the backbone solvation.
To this aim, we compared the backbone solvation of tau
oligomers from the R2 repeat with the tau oligomers from the
R2 repeat that are complexed with Aβ oligomers. Figure 10
illustrates the backbone solvation values for each residue in both
tau Aβ17 42 and tau Aβ1 42 and the corresponding tau
oligomers. For both tau oligomers, with 26 residues in the R2
repeat and the tau Aβ17 42 complex, the backbone solvation
valuesforallresiduesaresimilar,exceptforresidue37.Thesolvation
i sr e l a t e da l s ot ot h ec h a r a c t e ro fr e s i d u e3 7i nt h es e q u e n c e sf o rt h e
oligomers: in the Aβ sequence, it is G37 while in the tau it is D37,
indicating that small residues are more solvated. Thus, overall, tau
and tau Aβ17 42 oligomers illustrate similar stabilities. This
Figure 7. Fraction of the number of hydrogen bonds (in percentage)
between all β-strands compared with the initial oligomer structures of
Aβ tau for repeats R2, R3, and R4 (A) and of tau oligomers for repeats
R2, R3, and R4 (B).
Figure 8. CRbackbone backbone distanceofAβ tauforrepeats(A)
R2, (B) R3, and (C) R4. Three diﬀerent distances were examined:
averageddistancebetweentwoAβpeptides(blue),betweenAβpeptide
and tau monomer (red), and the averaged distance between two
monomers of tau (green).
Figure 9. CR backbone backbone distance of tau oligomers for
repeats R2, R3, and R4.
Figure 10. Average water molecules around each side chain Cβ carbon
within 4 Å.5178 dx.doi.org/10.1021/bi200400u |Biochemistry 2011, 50, 5172–5181
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result is in agreement with the hydrogen bond analysis for these
oligomers (Figure 7): both oligomers have relatively high
percentage of hydrogen bonds during the simulations.
For the full-length tau Aβ1 42 oligomers, the backbone solva-
tion illustrates smaller values compared with the tau oligomers
(Figure 7), indicating that the tau Aβ1 42 oligomers have better
β-sheetinteractionsandthushigherstabilitythanthetauoligomers.
’DISCUSSION
The aggregation of tau into NFTs, and Aβ into amlyoids, are
processes long known to be related to AD progression. More
recent experimental studies led to the proposition that Aβ may
directly or indirectly interact with tau to accelerate NFTs
formation.
4 8,10 14 Yet, the mechanism and the related interac-
tionsthroughwhichtauandAβself-assembletogetherhavebeen
controversial.Herein,weinvestigatetheinteractionsbetweentau
oligomers and Aβ oligomers at the molecular level to ﬁgure out
the preferred organizational state. Using all-atom MD simula-
tions in explicit solvent, we investigated the parallel oligomeric
architectures of three diﬀerent repeats in the tau protein—R2,
R3, and R4—and the interactions of these parallel tau architec-
tureswithAβ17 42oligomers.Whiletheabsenceofexperimental
examination of the interactions of puriﬁed tau variants with Aβ
oligomers limits our work to the prediction of the interactions
through computational tools, our models are based on experi-
mental data: the oligomers were based on the experimental model
by L€ uhrsetal.,
49aspreviously studiedbyMilleretal.
34forAβ17 42;
and the tau oligomer models are also based on experimental data
which illustrate highpropensityof β-structure intaurepeatsR2,R3,
and R4 pointing to likely intermolecular β-sheet interactions. In
addition to the β-structure of the peptide
306VQIVYK
311 in
repeat R3,
28 other studies by NMR spectroscopy,
57,58 CD
measurements,
59 and FTIR spectroscopy
60 suggest R-helical
structures in repeat R3. Herein, we did not test these R-helical
structures, and further investigations will need to be performed.
In our proposed Aβ tau models, we consider two main
factors: hydrophobicity and ﬂexibility of these domains. The
hydrophobicity factor plays a key role in forming hydrophobic
core and enhancing the interactions between Aβ oligomers and
tau oligomers. Recently, hydrophobicity and ﬂexibility were
illustrated to be the primary factors for oligomer assembly.
61 A
recent study
62 speculated that Aβ oligomers may be responsible
for accumulation of the transactive response DNA-binding
protein 43 (TDP-43). Further studies are needed to elucidate
the nature of the Aβ TDP-43 interactions.
Our study leads to a major conclusion: Aβ oligomers interact
better directly with fragments of the tau repeat R2 than repeats
R3 and R4. Further experiments, such as surface plasmon
resonancemaybeusefultoinvestigatetheaﬃnitiesofthevarious
tau repeats to Aβ oligomers. The U-turn root-mean-square
deviations (RMSDs) indicate that the oligomer of Aβ17 42 that
interacts with fragments of repeat R2 is slightly more stable than
theAβ17 42oligomer thatinteractswithfragmentsofrepeats R3
orR4(FigureS2).FigureS3illustratesthattheU-turnRMSDsof
tau repeats R2 and R3 oligomers are similar to values observed
previously
34 for Aβ17 42, and the RMSDs of oligomers of tau
repeats R4 are slightly larger. Overall, the R2, R3, and R4
oligomers are structurally stable in the turn region; however,
the β-sheet distances exhibit that the R2 oligomer cannot form a
stableoligomer alone,whilethetaurepeatsR3andR4oligomers
can form stable structures (Figure 9). Nonetheless, the tau R2
oligomer is the more likely candidate to interact with Aβ17 42 as
compared to R3 and R4 oligomers (Figure 8). We emphasize,
however,thatbecauseamyloidsincludingAβarepolymorphic,
63
Aβ taucomplexesarealsoexpectedtobepolymorphic,eitherin
their gross organizations or on a minor scale. The polymorphic
range can be broad, as was observed by cryo-EM, ssNMR, and
modeling, with and without ion binding.
34,35,56,64 66 Two likely
features that can lead to polymorphism is the U-turn shape, and
the organization between the sequences of tau repeats with
respect to the sequence of Aβ. Additional arrangements of the
Aβ and tau repeats which relate to the shift of the Aβ sequence
along the tau repeats can expand the polymorphic range of the
complexes. In addition, populations of the tau can be shifted:
whiletheR2oligomercannotformastableoligomeralone,itgets
stabilized when interacting with Aβ oligomer, thus shifting the
tau ensemble. Recent EM and AFM measurements revealed
highlypolymorphicﬁbrilsfortau
52,67,68thatdiﬀersigniﬁcantlyin
ﬁbril parameters such as cross section and twist. These measure-
ments illustrate irregular ﬁbril structures with no symmetry
which most likely relate to the turn shapes in the tau repeats.
Since the U-turn conformations in the tau repeats may diﬀer as
the sequence registration is shifted, the cross sections may be
diﬀerent, and consequently the number of protoﬁlamentsthatwind
around each other to form a mature ﬁbril may also be diﬀerent. In
summary, the U-turn appears to play a key role in the amyloid
polymorphic landscape, shifting the populations of the oligomers,
ﬁbrils, and gross-scale organization toward diﬀerent states, as
observed in the EM and AFM images and dimensions.
The hydrophobic regions in both R2 and R3 interact with the
microtubules (MTs) and stabilize them. In AD, tau becomes
excessively phosphorylated, loses its ability to bind to MTs, and
aggregates into NFTs. One can argue that when tau loses its
ability to bind to MTs, it interacts with Aβ to form a more stable
oligomer,acceleratingaggregation.Wefurthersuggestthatwhen
Aβinteracts directlywithtau repeat R2, thetau does notinteract
with the MTs, and consequently MTs degradation takes place,
leading to toxicity. Mutations in tau in repeats R2, R3, and R4
showednodecreaseinthebindingoftautotheMTs.
69However,
tau mutations lead to faster aggregation into paired helical ﬁlaments
(PHFs).
69 74 Some of the mutations may weaken tau’s ability to
bind to MTs
75 77 and thus cause degradation of the MT and
toxicity. A recent study
78 indicated that Aβ oligomers induce tau
aggregationandformationofβ-sheetrichneurotoxictauoligomers;
yet the mechanism for the toxicity is still controversial, and further
investigations will need to be performed.
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